| UniProt ID | DDX59_HUMAN | |
|---|---|---|
| UniProt AC | Q5T1V6 | |
| Protein Name | Probable ATP-dependent RNA helicase DDX59 | |
| Gene Name | DDX59 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 619 | |
| Subcellular Localization | Cytoplasm . Nucleus . Exhibits granular localization in the nucleus, as well as in the cytoplasm. | |
| Protein Description | ||
| Protein Sequence | MFVPRSLKIKRNANDDGKSCVAKIIKPDPEDLQLDKSRDVPVDAVATEAATIDRHISESCPFPSPGGQLAEVHSVSPEQGAKDSHPSEEPVKSFSKTQRWAEPGEPICVVCGRYGEYICDKTDEDVCSLECKAKHLLQVKEKEEKSKLSNPQKADSEPESPLNASYVYKEHPFILNLQEDQIENLKQQLGILVQGQEVTRPIIDFEHCSLPEVLNHNLKKSGYEVPTPIQMQMIPVGLLGRDILASADTGSGKTAAFLLPVIMRALFESKTPSALILTPTRELAIQIERQAKELMSGLPRMKTVLLVGGLPLPPQLYRLQQHVKVIIATPGRLLDIIKQSSVELCGVKIVVVDEADTMLKMGFQQQVLDILENIPNDCQTILVSATIPTSIEQLASQLLHNPVRIITGEKNLPCANVRQIILWVEDPAKKKKLFEILNDKKLFKPPVLVFVDCKLGADLLSEAVQKITGLKSISIHSEKSQIERKNILKGLLEGDYEVVVSTGVLGRGLDLISVRLVVNFDMPSSMDEYVHQIGRVGRLGQNGTAITFINNNSKRLFWDIAKRVKPTGSILPPQLLNSPYLHDQKRKEQQKDKQTQNDLVTGANLMDIIRKHDKSNSQK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MFVPRSLKIKRNA --CCCCCCCCCCCCC | 28.13 | 26074081 | |
| 19 | Phosphorylation | NANDDGKSCVAKIIK CCCCCCCCEEEEECC | 21.25 | - | |
| 23 | Acetylation | DGKSCVAKIIKPDPE CCCCEEEEECCCCHH | 25.27 | 25953088 | |
| 26 | Acetylation | SCVAKIIKPDPEDLQ CEEEEECCCCHHHCC | 47.01 | 66726701 | |
| 26 | Sumoylation | SCVAKIIKPDPEDLQ CEEEEECCCCHHHCC | 47.01 | 28112733 | |
| 26 | Sumoylation | SCVAKIIKPDPEDLQ CEEEEECCCCHHHCC | 47.01 | - | |
| 37 | Phosphorylation | EDLQLDKSRDVPVDA HHCCCCCCCCCCCCH | 33.12 | 25159151 | |
| 57 | Phosphorylation | ATIDRHISESCPFPS HHHHHHHHHCCCCCC | 19.82 | 29255136 | |
| 59 | Phosphorylation | IDRHISESCPFPSPG HHHHHHHCCCCCCCC | 21.94 | 29255136 | |
| 64 | Phosphorylation | SESCPFPSPGGQLAE HHCCCCCCCCCCEEE | 36.23 | 23401153 | |
| 74 | Phosphorylation | GQLAEVHSVSPEQGA CCEEEEEECCHHCCC | 29.48 | 23401153 | |
| 76 | Phosphorylation | LAEVHSVSPEQGAKD EEEEEECCHHCCCCC | 26.24 | 23401153 | |
| 93 | Phosphorylation | PSEEPVKSFSKTQRW CCCCCCCCCCCCCCC | 34.68 | 24719451 | |
| 149 | Phosphorylation | KEEKSKLSNPQKADS HHHHHHCCCCCCCCC | 50.64 | 28450419 | |
| 156 | Phosphorylation | SNPQKADSEPESPLN CCCCCCCCCCCCCCC | 60.97 | 25159151 | |
| 160 | Phosphorylation | KADSEPESPLNASYV CCCCCCCCCCCHHHE | 45.46 | 25159151 | |
| 165 | Phosphorylation | PESPLNASYVYKEHP CCCCCCHHHEECCCC | 17.66 | 21815630 | |
| 166 | Phosphorylation | ESPLNASYVYKEHPF CCCCCHHHEECCCCE | 12.85 | 23403867 | |
| 168 | Phosphorylation | PLNASYVYKEHPFIL CCCHHHEECCCCEEE | 11.48 | 23403867 | |
| 169 | Ubiquitination | LNASYVYKEHPFILN CCHHHEECCCCEEEE | 39.23 | - | |
| 221 | Phosphorylation | LNHNLKKSGYEVPTP HCCCHHHCCCCCCCC | 45.05 | 22964224 | |
| 223 | Phosphorylation | HNLKKSGYEVPTPIQ CCHHHCCCCCCCCCE | 22.35 | 22964224 | |
| 227 | Phosphorylation | KSGYEVPTPIQMQMI HCCCCCCCCCEEEEE | 37.89 | 22964224 | |
| 246 | Phosphorylation | LGRDILASADTGSGK HCHHHHHCCCCCCCH | 24.19 | 18669648 | |
| 253 | Ubiquitination | SADTGSGKTAAFLLP CCCCCCCHHHHHHHH | 36.37 | - | |
| 270 | Acetylation | MRALFESKTPSALIL HHHHHHCCCCCEEEE | 58.20 | 23954790 | |
| 270 | Ubiquitination | MRALFESKTPSALIL HHHHHHCCCCCEEEE | 58.20 | - | |
| 278 | Phosphorylation | TPSALILTPTRELAI CCCEEEECCHHHHHH | 18.67 | 24719451 | |
| 303 | Phosphorylation | SGLPRMKTVLLVGGL CCCCCCCEEEEECCC | 13.67 | - | |
| 317 | Phosphorylation | LPLPPQLYRLQQHVK CCCCHHHHHHHHCCE | 12.20 | - | |
| 410 | Acetylation | VRIITGEKNLPCANV EEEEECCCCCCCCCE | 66.19 | 25953088 | |
| 410 | Ubiquitination | VRIITGEKNLPCANV EEEEECCCCCCCCCE | 66.19 | - | |
| 432 | Acetylation | EDPAKKKKLFEILND CCHHHHHHHHHHHCC | 68.25 | 164187 | |
| 440 | Acetylation | LFEILNDKKLFKPPV HHHHHCCCCCCCCCE | 50.75 | 164191 | |
| 440 | Ubiquitination | LFEILNDKKLFKPPV HHHHHCCCCCCCCCE | 50.75 | - | |
| 466 | Ubiquitination | LLSEAVQKITGLKSI HHHHHHHHHHCCCCE | 35.32 | - | |
| 471 | Ubiquitination | VQKITGLKSISIHSE HHHHHCCCCEEECCC | 47.27 | - | |
| 479 | Ubiquitination | SISIHSEKSQIERKN CEEECCCCHHHHHHH | 51.15 | - | |
| 513 (in isoform 2) | Phosphorylation | - | 14.42 | 23663014 | |
| 524 (in isoform 2) | Phosphorylation | - | 31.49 | 23663014 | |
| 525 (in isoform 2) | Phosphorylation | - | 25.12 | 23663014 | |
| 529 (in isoform 2) | Phosphorylation | - | 10.04 | 23663014 | |
| 535 (in isoform 2) | Phosphorylation | - | 29.37 | 23663014 | |
| 536 (in isoform 2) | Phosphorylation | - | 4.39 | 23663014 | |
| 562 | Ubiquitination | RLFWDIAKRVKPTGS EEEHHHHHHCCCCCC | 59.04 | - | |
| 578 | Phosphorylation | LPPQLLNSPYLHDQK CCHHHHCCCCCCHHH | 18.19 | 25159151 | |
| 593 | Ubiquitination | RKEQQKDKQTQNDLV HHHHHHCHHHHHHHH | 63.38 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DDX59_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX59_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX59_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DDX59_HUMAN | DDX59 | physical | 28561026 | |
| HS90A_HUMAN | HSP90AA1 | physical | 28561026 | |
| HS90B_HUMAN | HSP90AB1 | physical | 28561026 | |
| HSP7C_HUMAN | HSPA8 | physical | 28561026 | |
| STIP1_HUMAN | STIP1 | physical | 28561026 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 174300 | Orofaciodigital syndrome 5 (OFD5) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-160, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64 AND SER-76, AND MASSSPECTROMETRY. | |